The following is a summary of “Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V ...

Hyundai Bio’s drug candidate, Xafty, is a new formulation of niclosamide, used for decades to treat infections caused by parasitic worms and, in recent years, proposed as a potential therapy for ...

After hours: March 14 at 4:05:07 PM EDT Loading Chart for MTVA ...

The most stable drug molecules docked with DUSP6 and TAB2 are tanespimycin and niclosamide, with binding energies of −5.67 and −9.26 kcal/mol, respectively; the most stable drug binding to 3CLpro is ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

随后，刘教授提出了目前研究现状下，还尚未回答和解决的科学问题。为了进一步探究这些问题，刘教授进一步发现了 表达 CLIC1 的外泌体与 DCs 细胞膜上 TMEM16F 的相互作用，在利用 Niclosamide 阻断 TMEM16F-CLIC1 相互作用后，缓解了小鼠心脏移植后的排斥反应。